BioMimetic Therapeutics (BMTI)
BioMimetic Therapeutics Cash Flow
- Quarterly: March 2012 - December 2009 Previous Quarters
- Annual
| Cash Flow - Operations | 2012-03 | 2011-12 | 2011-09 | 2011-06 | 2011-03 | 2010-12 | 2010-09 | 2010-06 | 2010-03 | 2009-12 |
| Net Income | -6.117M | -9.873M | -7.122M | -8.241M | -7.953M | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro |
| Depreciation, Depletion, Amortization | 0.3754M | 0.3721M | 0.3692M | 0.2797M | 0.2723M | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro |
| Other Non-Cash Items | 0.8651M | 3.890M | 0.9171M | 0.983M | 0.9051M | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro |
| Total Non-Cash Items | 1.240M | 4.263M | 1.286M | 1.263M | 1.177M | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro |
| Deferred Income Taxes | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | |||||
| Total Changes in Assets/Liabilities | -2.006M | 0.3728M | -2.055M | -0.6695M | -1.100M | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro |
| Other Operating Activities | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | |||||
| Net Cash from Operating Activities | -6.883M | -5.238M | -7.891M | -7.648M | -7.876M | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro |
| Cash Flow - Investing | 2012-03 | 2011-12 | 2011-09 | 2011-06 | 2011-03 | 2010-12 | 2010-09 | 2010-06 | 2010-03 | 2009-12 |
| Capital Expenditures | -0.0093M | -0.0225M | -0.14M | -1.053M | -0.6926M | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro |
| Acquisitions, Divestitures | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | |||||
| Investments | 8.894M | 2.334M | 13.04M | 0.3648M | 22.07M | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro |
| Other Investing Activities | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | |||||
| Cash Flow - Financing | 2012-03 | 2011-12 | 2011-09 | 2011-06 | 2011-03 | 2010-12 | 2010-09 | 2010-06 | 2010-03 | 2009-12 |
| Net Cash from Investing Activities | 8.801M | 2.196M | 12.82M | -0.8884M | 21.17M | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro |
| Debt Issued | -0.0173M | -0.0207M | -0.0207M | -0.0271M | -0.0102M | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro |
| Equity Issued | 0.0452M | 0.0727M | 0.0779M | 0.0972M | 0.0667M | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro |
| Dividends Paid | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | |||||
| Other Financing Activities | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | |||||
| Net Cash from Financing Activities | 0.0279M | 0.0521M | 0.0572M | 0.0701M | 0.0565M | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro |
| Foreign Exchange Effects | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | |||||
| Net Change in Cash & Cash Equivalents | 1.945M | -2.990M | 4.983M | -8.466M | 13.35M | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro |
| Cash at beginning of period | 18.50M | 11.63M | 18.50M | 21.49M | 16.51M | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro |
| Cash at end of period | 20.45M | 18.50M | 21.49M | 16.51M | 24.98M | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro |
